Cargando...
EZH2 inhibitor GSK343 inhibits sepsis-induced intestinal disorders
Enhancer of zeste homolog 2 (EZH2) is positively associated with poor clinical outcomes in a number of aggressive tumors. Recent studies have demonstrated that inhibition of EZH2 also suppressed the inflammatory response during sepsis. The present study aimed to investigate whether an inhibitor of E...
Guardado en:
| Publicado en: | Exp Ther Med |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
D.A. Spandidos
2021
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7967880/ https://ncbi.nlm.nih.gov/pubmed/33747174 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2021.9854 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|